您的位置: 首页 > 农业专利 > 详情页

Anti OX40 antibody and its application
专利权人:
ABBVIE BIOTHERAPEUTICS INC.
发明人:
HARDING, Fiona A.
申请号:
PE2019001249
公开号:
PE20191403A1
申请日:
2017.12.15
申请国别(地区):
PE
年份:
2019
代理人:
摘要:
It refers to an anti OX40 antibody, including VH chains with three SEQ ID CDR numbers 101, 102 and 103; and VL chains with three CDRs with SEQ ID numbers 104, 105 and 106. He also mentioned a nucleic acid, a vector, a bone cell, a pharmacological compound, including these antibodies and methods for processing, as well as the treatment of bladder cancer, breast cancer, gastric cancer, etc.Referido a un anticuerpo anti-OX40 que comprende una cadena VH que comprende tres CDR de SEQ ID NOs: 101, 102 y 103; y una cadena VL que comprende tres CDR de SEQ ID NOs: 104, 105 y 106. Tambien se refiere a un acido nucleico, un vector, una celula huesped, una composicion farmaceutica incluyen dichos anticuerpos y metodos para su elaboracion; ademas de uso para tratar el cancer de vejiga, mama, gastrico, entre otros.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充